How Rare Diseases Were Affected By The COVID Pandemic

By Joyce Moore, Head of Rare Disease Solutions, THREAD

The latest issue of Raconteur (published as a supplement in The Times, UK) took a deep look at the rare disease landscape, including how rare diseases were affected by the COVID pandemic, and how patients who are engaged in the drug development process through clinical trials can build connections through digital platforms. It also highlighted how the increasing use of decentralized clinical trials (DCTs) is poised to improve both the patient experience and outcomes in the coming years. 

To learn more about THREAD, visit their Clinical Leader page.